Brief: Novabay Pharmaceuticals Reports First Quarter 2021 Financial Results
06/05/2021 21:38
May 6 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS REPORTS FIRST QUARTER 2021
FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.04
Source text for Eikon: ID:nBw5Y8zC4a
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing